Leslie Sloan's most recent trade in Aeglea BioTherapeutics Inc was a trade of 130,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 23, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics Inc | Leslie Sloan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Leslie Sloan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Leslie Sloan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) |